v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2019 $ 142,361 $ 4 $ 271,182 $ (128,822) $ (3)
Balance (in shares) at Dec. 31, 2019   16,723,128      
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (32,944)     (32,944)  
Acquisition consideration 39,388   39,388    
Acquisition consideration (in shares)   1,025,782      
Restricted stock 6,196   6,196    
Restricted stock (in shares)   162,125      
Stock option exercise $ 1,650   1,650    
Stock option exercise (in shares) 53,270 53,270      
Issuance of common stock, net of issuance cost $ 70,207 $ 1 70,206    
Issuance of common stock, net of issuance cost (in shares)   1,595,986      
Other comprehensive income (loss) 7,910       7,910
Balance at Dec. 31, 2020 234,768 $ 5 388,622 (161,766) 7,907
Balance (in shares) at Dec. 31, 2020   19,560,291      
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (16,260)     (16,260)  
Acquisition consideration 298   298    
Acquisition consideration (in shares)   4,599      
Restricted stock 5,842   5,842    
Restricted stock (in shares)   107,902      
Stock option exercise $ 137   137    
Stock option exercise (in shares) 4,422 4,422      
Other comprehensive income (loss) $ 584       584
Balance at Dec. 31, 2021 $ 225,369 $ 5 394,899 (178,026) 8,491
Balance (in shares) at Dec. 31, 2021 19,677,214 19,677,214      
Increase (Decrease) in Stockholders' Equity          
Net income (loss) $ 1,258     1,258  
Acquisition consideration 9,707   9,707    
Acquisition consideration (in shares)   208,140      
Stock portion of Apifix anniversary installment payment 10,410   10,410    
Stock portion of Apifix anniversary installment payment (in shares)   185,811      
Restricted stock 6,449   6,449    
Restricted stock (in shares)   188,537      
Stock option exercise $ 63   63    
Stock option exercise (in shares) 2,010 2,010      
Issuance of common stock, net of issuance cost $ 139,283 $ 1 139,282    
Issuance of common stock, net of issuance cost (in shares)   2,616,250      
Other comprehensive income (loss) (13,891)       (13,891)
Balance at Dec. 31, 2022 $ 378,648 $ 6 $ 560,810 $ (176,768) $ (5,400)
Balance (in shares) at Dec. 31, 2022 22,877,962 22,877,962